Home › Drug Product Listings

Drug Product Listings

Please note - this is not a complete list of products available in Canada. For a complete list of drug products marketed in Canada, visit the Health Canada Drug Product Database
A (35) | B (19) | C (21) | D (34) | E (35) | F (11) | G (9) | H (9) | I (21) | K (1) | L (24) | M (12) | N (6) | O (10) | P (27) | R (14) | S (24) | T (26) | U (3) | V (12) | W (1) | Z (4)
Generic Namesort icon Common Trade Name(s) Classification Date Marketed in Canada (yyyy/mm/dd)
Pasireotide Signifor Synthetic analogue of somatostatin 2013/11/26
Patiromer Veltassa Potassium binder 2020/03/09
Pazopanib Votrient Antineoplastic agent 2011/08/25
Perampanel Fycompa Anticonvulsant 2013/09/04
Pertuzumab Perjeta Antineoplastic agent 2013/04/23
Phosphate Effervescent Phosphate Sandoz 2017/01/01
Pirfenidone Esbriet Anti-fibrotic agent 2013/01
Plerixafor Mozobil Hematopoietic agent 2012/01/26
Pneumococcal 13-valent conjugate vaccine Prevnar 13 Vaccine 2010/03/17
Polidocanol Varithena Sclerosing agent 2015/08/04
Polyethylene glycol 3350 Lax-a-day Laxative 2009/03/09
Polyethylene glycol 3350 Pegalax Laxative
Pomalidomide Pomalyst Antineoplastic agent; immunmodulator 2014/02/24
Prasugrel Effient Platelet aggregation inhibitor 2010/05/17
Prasugrel Effient Antiplatelet agent 2020/01/31
Pregabalin Lyrica Analgesic
Probenecid Benuryl Uricosuric agent
Progesterone Endometrin Progestin 2010/02/21
Propiverine Mictoryl; Mictoryl Pediatric Anticholinergic and antispasmodic agent 2017/04/13
Propofol Propofol Injection Anesthetic, sedative 2010/06/01
Propoxyphene Darvon-N; 642 Narcotic
Prucalopride Resotran Enterokinetic agent 2012/01/13
Regorafenib Stivarga Antineoplastic agent 2013/03/11
Ribociclib Kisqali Antineoplastic agent 2018/11/26
Rilpivirine Edurant Antiviral agent 2011/08/08
Risankizumab Skyrizi Interleukin-23 inihbitor 2019/05/13
Risedronate Actonel DR Bone metabolism regulator 2011/09/28
Risedronate + Calcium carbonate Actonel APC
Risedronate sodium Actonel Bisphosphonate
Roflumilast Daxas Phosphodiesterase 4 (PDE4) Inhibitor 2010/11/25
Romosozumab Evenity Bone formation agent 2019/08/12
Rosiglitazone + glimepiride Avandaryl 2011/03/31
Rotigotine Neupro Antiparkinsonian agent / Dopamine agonist 2013/09/12
Rufinamide Banzel Antiepileptic 2011/09
Rupatadine Rupall Antihistamine, second generation 2017/01/25
Ruxolitinib Jakavi Antineoplastic agent 2012/07/18
Syndicate content